Estimating the magnitude of female genital mutilation/cutting in Norway: an extrapolation model

BMC Public Health
Mai M ZiyadaR Elise B Johansen

Abstract

With emphasis on policy implications, the main objective of this study was to estimate the numbers of two main groups affected by FGM/C in Norway: 1) those already subjected to FGM/C and therefore potentially in need for health care and 2) those at risk of FGM/C and consequently the target of preventive and protective measures. Special attention has been paid to type III as it is associated with more severe complications. Register data from Statistics Norway (SSB) was combined with population-based survey data on FGM/C in the women/girls' countries of origin. As of January 1(st) 2013, there were 44,467 first and second-generation female immigrants residing in Norway whose country of origin is one of the 29 countries where FGM/C is well documented. About 40 pct. of these women and girls are estimated to have already been subjected to FGM/C prior to immigration to Norway. Type III is estimated in around 50 pct. of those already subjected to FGM/C. Further, a total of 15,500 girls are identified as potentially at risk, out of which an approximate number of girls ranging between 3000 and 7900 are estimated to be at risk of FGM/C. Reliable estimates on FGM/C are important for evidence-based policies. The study findings indicate that...Continue Reading

References

Oct 1, 1995·British Journal of Obstetrics and Gynaecology·M McCaffreyH Gordon
Jul 1, 1996·Acta Obstetricia Et Gynecologica Scandinavica·J Sundby
Nov 26, 2002·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·R J CookM F Fathalla
Oct 14, 2004·Journal de gynécologie, obstétrique et biologie de la reproduction·X CarcopinoL Boubli
Feb 3, 2005·Journal de gynécologie, obstétrique et biologie de la reproduction·P CollinetJ-L Leroy
Apr 6, 2006·Health Care for Women International·Els LeyeMarleen Temmerman
Jun 29, 2006·BMJ : British Medical Journal·Susan ElmusharafLars Almroth
Nov 10, 2007·Nursing Standard·Maligaye Bikoo
May 10, 2008·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Els LeyeMarleen Temmerman
May 13, 2011·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Dominique DubourgSophie Maes
Feb 9, 2012·International Journal of Women's Health·Abdi A GeleJohanne Sundby
Mar 29, 2013·Ethnicity & Health·Erick VloeberghsMaria van den Muijsenbergh
Jul 12, 2013·Obstetrics and Gynecology International·Inger-Lise Lien, Jon-Håkon Schultz
Jun 9, 2014·Reproductive Health Matters·Ingvild Bergom Lunde, Mette Sagbakken

❮ Previous
Next ❯

Citations

Apr 5, 2018·BMC Health Services Research·R Elise B JohansenEls Leye
Apr 8, 2018·Reproductive Health·Gro Møller ChristoffersenVibeke Naeser
Mar 1, 2020·International Journal of Environmental Research and Public Health·Sabera TurkmaniAngela J Dawson
Nov 13, 2015·American Journal of Public Health·Callie A M AttaAmy Metcalfe
Apr 20, 2018·BMC Public Health·Vivian N MbanyaBernadette Kumar
Sep 20, 2016·Acta Obstetricia Et Gynecologica Scandinavica·Elinor Clarke, Yana Richens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.